Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.89m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Trading update and interim dividend declaration

5 Oct 2023 07:00

RNS Number : 7261O
Tavistock Investments PLC
05 October 2023
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

 

Tavistock Investments Plc

("Tavistock", the "Group" or the "Company")

 

Trading update and interim dividend declaration

 

5 October 2023

 

The Board of Tavistock is pleased to announce that the Group's trading in the first five months of the current financial year to 31 March 2024 is significantly ahead of the equivalent period in the previous financial year.

 

The Company's unaudited management accounts show that for the five months to 31 August 2023 gross revenues have increased by 19% to £17.2 million (prior year equivalent period: £14.5 million), gross margin has increased by 40% to £6.7 million (prior year equivalent period: £4.8 million) and EBITDA (earnings before interest taxation depreciation and amortisation) has risen thirteenfold to £1.6 million (prior year equivalent period: EBITDA loss £0.14 million).

 

The Company has implemented the new Consumer Duty regime (which became effective on 31 July 2023) and has completed its review of all British Steel Defined Benefit Pension Transfer cases with minimal uninsured cost being incurred.

 

In April 2023 the Company announced the acquisition of Precise Protect Limited ("Precise Protect"). Precise Protect is a profitable and fast-growing UK wide protection business based in Bangor, Northern Ireland. The Board believes that Precise Protect will be a major contributor to the future profitability of the Group and is pleased to report that it has been successfully integrated into the Group.

 

Following this transaction, Tavistock has a network of over 400 advisers and other business introducers working with more than 110,000 UK retail clients, whose assets are estimated to exceed £6 billion in value, as well as 350 corporate and affinity clients with some 16,000 employees. The Company is thus well placed to pursue its ambitious growth plans.

 

Interim dividend

 

In keeping with its stated objective of developing and maintaining a dividend stream for the benefit of the Company's shareholders, the Board is pleased to declare an interim dividend of 0.07 pence gross per ordinary share. The ex-dividend date for the interim dividend will be Thursday, 30 November 2023 and the associated record date will be Friday, 1 December 2023. The dividend will be paid on Friday 15 December 2023.

 

Brian Raven, Tavistock's Chief Executive, commented: "The Board's focus continues to be on optimising the operating structure of the Group and delivering value to shareholders through continued growth. We remain ambitious and acquisitive and look forward to updating shareholders on progress in due course."

 

For further information:

 

Tavistock Investments Plc

Oliver Cooke

Brian Raven

      Tel: 01753 867000

 

Allenby Capital Limited

(Nominated adviser and broker)

Corporate Finance:

Nick Naylor, Nick Athanas, Daniel Dearden-Williams

Sales and Corporate Broking:

Tony Quirke

 

Tel: 020 3328 5656

Powerscourt

Gilly Lock

Roxane Girard

 

 

Tel: 07711 380 007

    020 7250 1446

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZMGGVDDGFZM
Date   Source Headline
29th May 20269:00 amRNSDirectorate Change
2nd Apr 20267:00 amRNSCompletion of Acquisition
30th Mar 20262:55 pmRNSChange of Auditor
5th Feb 20267:00 amRNSFurther Update on Litigation with Titan
20th Jan 20267:00 amRNSAppointment of Nominated Adviser and Broker
23rd Dec 20257:00 amRNSInterim Results
23rd Dec 20257:00 amRNSInterim Results
17th Dec 202512:13 pmRNSFurther update re ongoing litigation with Titan
16th Dec 20257:00 amRNSUpdate re ongoing litigation with Titan
6th Nov 202512:00 pmRNSResult of AGM
2nd Oct 20257:00 amRNSUpdate re ongoing litigation
30th Sep 20255:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSNotice of AGM
25th Sep 20257:00 amRNSTransfer of Shares from treasury to EBT and TVR
24th Sep 202510:57 amRNSDirector/PDMR Shareholding
18th Sep 20257:00 amRNSFinal Results for the Year Ended 31 March 2025
15th Sep 20252:08 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSStrategic refocus and acquisition of Lifetime
7th Jul 202512:40 pmRNSDirector / PDMR Dealing
8th Apr 20254:15 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20255:00 pmRNSTotal Voting Rights
20th Feb 20257:00 amRNSCompletion of acquisition of Alpha Beta Partners
14th Feb 202512:08 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSTransaction in Own Shares,Director Dealing and TVR
6th Feb 20252:16 pmRNSDirector/PDMR Shareholding
30th Jan 202511:00 amRNSHolding(s) in Company
30th Jan 20259:53 amRNSHolding(s) in Company
6th Jan 202511:54 amRNSHolding(s) in Company
2nd Jan 20255:45 pmRNSTotal Voting Rights - Replacement
31st Dec 20241:30 pmRNSTotal Voting Rights
12th Dec 202412:00 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 202411:30 amRNSResult of AGM
9th Dec 202412:49 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 20247:00 amRNSInterim Results
2nd Dec 20247:00 amRNSRepositioning of Retail Asset Management business
22nd Nov 20247:00 amRNSStrategic acquisition and completion of disposal
11th Nov 20243:38 pmRNSNotice of AGM
30th Oct 202411:25 amRNSResult of General Meeting
2nd Oct 20243:50 pmRNSPublication of Circular and Notice of GM
2nd Oct 202411:32 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSProposed disposals for up to £37.75 million
30th Sep 20247:00 amRNSFinal Results for the Year Ended 31 March 2024
19th Sep 20242:47 pmRNSUpdate on Titan Dispute
11th Jul 20247:00 amRNSFollow up to Titan termination announcement
8th Jul 20244:19 pmRNSTermination of strategic partnership
28th Jun 202410:16 amRNSStatement re press speculation
21st Jun 202410:31 amRNSDirectorate Change
31st May 20247:00 amRNSBoard role change
8th Jan 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.